Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 4, 1996, Pages 992-998

  Wondrack, L ^a   Massa, M ^a   Yang, B V ^a   Sutcliffe, J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; ESTERASE; JOSAMYCIN; MACROLIDE; ROSARAMICIN; SPIRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG HYDROLYSIS; DRUG INACTIVATION; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0029986588     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.4.992     Document Type: Article

References (55)

1. Andremont, A., G. Gerbaud, and P. Courvalin. 1986. Plasmid-mediated high-level resistance to erythromycin in Escherichia coli. Antimicrob. Agents Chemother 29:515-518.
2. Arndt, F. 1943. Nitrosomethylurea, p. 461. In A. H. Blatt (ed ), Organic synthesis, collective vol. II. John Wiley & Sons, New York.
3. Arthur, M., A. Andremont, and P. Courvalin. 1987. Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin. Antimicrob. Agents Chemother 31:404-409.
4. Arthur, M., D. Autissier, and P. Courvalin. 1986. Analysis of the nucleotide sequence of the ereB gene encoding the erythromycin esterase type II. Nucleic Acids Res. 14:4987-4999
5. Arthur, M., C. Molinas, C. Mabilat, and P. Courvalin. 1990. Detection of erythromycin resistance by the polymerase chain reaction using primers in conserved regions of erm rRNA methylase genes Antimicrob. Agents Chemother. 34:2024-2026.
6. Barthélémy, P., D. Autissier, G. Gerbaud, and P. Courvalin. 1984. Enzymatic hydrolysis of erythromycin by a strain of Escherichia coli: a new mechanism of resistance. J. Antibiot. 37:1692-1696.
7. Brain, E. G. March 1989. European patent 307,177.
8. Bright, G. M. June 1985. U.S patent 4,526,889.
9. Bright, G. M., A. A. Nagel, J. Bordner, K. A. Desai, J, N. Dibrino, J. Nowakowska, L. Vincent, R. M. Watrous, F. C. Sciavolino, A. R. English, J. A. Retsema, M. R. Anderson, L. A. Brennan, R. J. Borovoy, C. R. Cimochowski, J. A. Faiella, A. E. Girard, D. Girard, C. Herbert, M. Manousos, and R. Mason. 1988. Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives: a new class of macrolide antibiotics, the azalides J Antibiot. 41:1028-1047.
10. Brisson-Noël, A., P. Delrieu, D. Samain, and P. Courvalin. 1988. Inactivation of lincosamide antibiotics in Staphylococcus J. Biol. Chem. 263:15880-15887
11. Celmer, W. D., W. P. Cullen, C. E. Moppett, J. B. Routien, R. Shibakawa, and J. Tome. July 1977. U.S. patent 4,038,383.
12. Courvalin, P. 1994. Transfer of antibiotic resistance genes between gram-positive and gram-negative bacteria. Antimicrob. Agents Chemother. 38: 1447-1451.
13. Devriese, L. A. 1980. Two new types of resistance to lincomycin in pathogenic staphylococci from animals. Ann. Microbiol. (Inst. Pasteur) 131:261-266.
14. Djokic, S., G. Kobrehel, G. Lazarevski, N. Lopotar, Z. Tamburasev, G. Kamenar, A. Nagl, and I. Vickovic. 1986. Erythromycin series. Part II. Ring expansion of erythromycin A oxime by the Beckmann rearrangement J. Chem. Soc. Perkin Trans I 1986:1881-1890
15. Dubnau, D. 1984 Translational attenuation: the regulation of bacterial resistance to the macrolide-lincosamide-streptogramin B antibiotics. Crit Rev. Biochem. 16:103-132.
16. Eady, E. A., J. I. Ross, J. L. Tipper, C. E. Walters, J. H. Cove, and W. C. Noble. 1993. Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J. Antimicrob. Chemother 31:211-217.
17. Fernandez-Munoz, R., R. E. Monro, R. Torres-Pinedo, and D. Vasques. 1971. Substrate- and antibiotic-binding sites at the peptidyl-transferase centre of Escherichia coli ribosomes Studies on the chloramphenicol, lincomycin and erythromycin sites. Eur. J. Biochem. 23:185-193.
18. Ferre, F. 1992. Quantitative or semi-quantitative PCR. reality versus myth. PCR Methods Appl 2:1-9.
19. Higgins, C. F., S. C. Hyde, M. M. Mimmack, U. Gileadi, D. R. Gill, and M. P. Gallagher. 1990 Binding protein-dependent transport systems J. Bioenerg. Biomembr. 22:571-592.
20. Janosi, L., Y. Nakajima, and H. Hashimoto. 1990. Characterization of plasmids that confer inducible resistance to 14-membered macrolides and streptogramin type B antibiotics in Staphylococcus aureus. Microbiol. Immunol. 34:723-735.
21. Jenkins, G., and E. Cundliffe. 1991. Cloning and characterization of two genes from Streptomyces lividans that confer inducible resistance to lincomycin and macrolide antibiotics. Gene 108:55-62.
22. Jenssen, W. D., S. Thakker-Varia, D. T. Dubin. and M. P. Weinstein. 1987 Prevalence of macrolides-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci. Antimicrob. Agents Chemother. 31:883-888.
23. Kono, M., K. O'Hara, and T. Ebisu. 1992. Purification and characterization of macrolide 2′-phosphotransferase type II from a strain of Escherichia coli highly resistant to macrolide antibiotics. FEMS Microbiol. Lett. 97:89-94.
24. Kuo, M.-S., D. G. Chirby, A. D. Argoudelis, J. I. Cialdella, J. H. Coats, and V. P. Marshall. 1989. Microbial glycosylation of erythromycin A. Antimicrob. Agents Chemother. 33:2089-2091.
25. Kurath, P., P. H. Jones, R. S. Egan, and T. J. Perun. 1971. Acid degradation of erythromycin A and erythiomycin B Experientia 27:362.
26. Lai, C. J., and B. Weisblum. 1971. Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 68:856-860.
27. Lampson, B. C., W. von David, and J. T. Parisi. 1986. Novel mechanism for plasmid-mediated erythromycin resistance by pNE24 from Staphylococcus epidermidis. Antimicrob. Agents Chemother. 30:653-658.
28. Leclercq, R., A. Brisson-Noël, J. Duval, and P. Courvalin. 1987. Phenotypic expression and genetic heterogeneity of lincosamide inactivation in Staphylococcus spp. Antimicrob. Agents Chemother 31:1887-1891.
29. Leclercq, R., and P. Courvalin. 1991 Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification, Antimicrob. Agents Chemother. 35:1267-1272
30. Leclercq, R., and P. Courvalin. 1991. Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria. Antimicrob Agents Chemother. 35:1273-1276.
31. Leclercq, R., and P. Courvalin. 1993. Mechanisms of resistance to macrolides and functionally related antibiotics, p. 125-141. In A J. Bryskier, J. P. Butzler, H. C. Neu, and P. M. Tulkens (ed.), Macrolides - chemistry, pharmacology and clinical uses. Arnette, Blackwell, Paris
32. Le Goffic, F., M. L. Capmau, J. Abbe, C. Cerceau, A. Dublanchet, and J. Duval. 1977. Plasmid-mediated pristinamycin resistance: PH1A, a pristinamycin 1A hydrolase. Ann. Inst. Pasteur (Paris) 128:471-474.
33. Le Goffic, F., M. L. Capmau, M. L. Bonnet, C. Cerceau, C. J. Soussy, A. Dublanchet, and J. Duval. 1977. Plasmid-mediated pristinamycin resistance: PACIIA, a new enzyme which modifies pristinamycin IIA. J. Antibiol 30: 665-669.
34. Mabilat, C., S. Goussard, W. Sougakoff, R. C. Spencer, and P. Courvalin. 1990. Direct sequencing of the amplified structural gene and promoter for the extended-broad-spectrum β-lactamase TEM-9 (RHH-1) of Klebsiella pneumoniae. Plasmid 23:27-34.
35. Matsuoka, M., K. Endou, S. Saitoh, M. Katoh, and Y. Nakajima. 1995. A mechanism of resistance to partial macrolide and streptogramin B antibiotics in Staphylococcus aureus clinically isolated in Hungary. Biol. Pharm Bull. 18:1482-1486
36. Matsuoka, M., L. Janosi, K. Endou, S. Saitoh, H. Hashimoto, and Y. Nakajima. 1993. An increase of 63kDa-protein present in the cell membranes of Staphylococcus aureus that bears a plasmid mediating inducible resistance to partial macrolide and streptogramin B antibiotics Biol Pharm Bull. 16:1288-1290.
37. Miller, J. H. 1972. Experiments in molecular genetics, p. 432. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. N.Y.
38. Milton, E. D., C. L. Hewitt, and C. R. Harwood. 1992. Cloning and sequencing of a plasmid-mediated erythromycin resistance determinant from Staphylococcus xylosus. FEMS Microbiol Lett. 97:141-147.
39. Noguchi, N., A. Emura, H. Matsuyama, K. O'Hara, M. Sasatsu, and M. Kono. 1995. Nucleotide sequence and characterization of erythromycin resistance determinant that encodes macrolide 2′-phosphotransferase I in Escherichia coli. Antimicrob. Agents Chemother. 39:2359-2363.
40. O'Hara, K. 1994. Application of nuclear magnetic resonance spectrometry to measure the activity of bacterial macrolide esterase. Microbios 79:231-239
41. O'Hara, K., T. Kanda, K. Ohmiya, T. Ebisu, and M. Kono. 1989. Purification and characterization of macrolide 2′-phosphotransferase from a strain of Escherichia coli that is highly resistant to erythromycin. Antimicrob. Agents Chemother. 33:1354-1357.
42. Ounissi, H., and P. Courvalin. 1985. Nucleotide sequence of the gene ereA encoding the erythromycin esterase in Escherichia coli. Gene 35:271-278.
43. Ross, J. I., E. A. Eady, J. H. Cove, and S. Baumberg. 1995. Identification of a chromosomally encoded ABC-transport system with which the staphylococcal erythromycin exporter MsrA may interact. Gene 153:93-98.
44. Ross, J. I., E. A. Eady, J. H. Cove, W. J. Cunliffe, S. Baumberg, and J. C. Wootton. 1990 Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol Microbiol. 4:1207-1214.
45. Ross, J. I., A. M. Farrell, E. A. Eady, J. H. Cove, and W. J. Cunliffe. 1989. Characterization and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis. J. Antimicrob. Chemother. 24:851-862.
46. Schoner, B., M. Geistlich, P. Rosteck, Jr., R. N. Rao, E. Seno, P. Reynolds, K. Cox, S. Burgett, and C. Hershberger. 1992. Sequence similarity between macrolide-resistance determinants and ATP-binding transport proteins. Gene 115:93-96
47. Slawinski, W., H. Bojarska-Dahlig, T. Glabski, I. Dziegielewska, M. Biedrzycki, and S. Naperty. 1975. The structure of erythromycin A cyclic carbonate. Recueil des Travaux Chimiques de Pays-Bas 94:236-238.
48. Weisblum, B. 1985. Inducible resistance to macrolides, lincosamides, and streptogramin type B antibiotics. the resistance phenotype, its biological diversity, and structural elements that regulate expression - a review. J. Antimicrob. Chemother. 16(Suppl, A):63-90.
49. Weisblum, B. 1995. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother. 39:577-585.
50. Weisblum, B. 1995. Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob. Agents Chemother. 39:797-805.
51. Westh, H., D. M. Hougaard, J. Vuust, and V. T. Rosdahl. 1995. Prevalence of erm gene classes in erythromycin-resistant Staphylococcus aureus strains isolated between 1959 and 1988. Antimicrob. Agents Chemother. 39:369-373.
52. Wiley, P. F., K. Gerzon, E. H. Flynn, M. V. Sigal, Jr., O. Weaver, U. C. Quarck, R. R. Chauvette, and R. Monahan. 1957. Structure of erythromycin. J. Am. Chem Soc. 79:6062-6070.
53. Wilkening, R. R., R. W. Ratcliffe, G. A. Doss, K. Bartizal, A. Graham, and C. Herbert. 1993. The synthesis of novel 8a-aza-8a-homoerythromycin derivatives via the Beckmann rearrangement of (9Z)-erythromycin A oxime Bioorg. Med. Chem. Lett 3:1287-1292.
54. Wondrack, L., M. Massa, B. Yang, and J. Sutcliffe. 1994 A clinical strain of Staphylococcus aureus produces an esterase that degrades macrolides, abstr. 7, p. 21. In Program and abstracts for the First International Conference for Antibiotic Resistance. Society for Industrial Microbiology, Fairfax, Va.
55. Wondrack, L., and J. Suteliffe. 1995 Staphylococcus strains with MS phenotype efflux and inactivate erythromycin, a 14-membered macrolide, abstr. A-84, p. 158. In Abstracts of the 95th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington. D.C.